Albertsons (ACI) Reports Q4 2025 Earnings with Sales Growth and Shareholder Returns
Albertsons (ACI) reported Q4 2025 earnings with identical sales increasing 0.7%, despite a 145 basis-point headwind from pharmacy pressures. The company achieved $903 million in adjusted EBITDA and $0.48 in adjusted EPS, while returning $1.8 billion to shareholders through dividends and share repurchases.
Topics: digital sales dividends earnings EBITDA loyalty membership sales share repurchases